The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Issue of Equity and Total Voting Rights

1 Oct 2019 07:00

RNS Number : 2435O
PROACTIS Holdings PLC
01 October 2019
 

 

 

Proactis Holdings PLC

 

Issue of Equity

and Total Voting Rights

 

PROACTIS Holdings PLC ("PROACTIS", the "Group" or the "Company"), the global spend management solution provider, announces that it has finalised the payment of the remaining contingent consideration due to the vendor of Proactis Benelux B.V. ("BV" and "Seller"), as disclosed and detailed in the Company's annual report for the year ended 31 July 2018.

 

BV was acquired on 24 October 2017 (the "Acquisition") and agreements were signed in March 2019 to amend the amounts payable as deferred consideration to the Seller from a maximum of €1.5m to an amount of €250,000 payable in cash and a final one-off amount of €400,000 payable in cash or shares (the "Revised Agreement"), at the Company's sole discretion. Pursuant to the Revised Agreement, provided the Seller remained an employee of the Company at 31 July 2019, he would be entitled to this final one-off payment of €400,000. The Company has elected to satisfy half of this in cash and half in new shares.

 

The Company is therefore issuing 313,832 new ordinary shares of 10p each in the share capital of the Company ("Ordinary Shares") to the Seller as final settlement of the share element of this deferred consideration. The 313,832 new ordinary shares represent 0.33 per cent. of the current issued share capital of the Company. The issue price of 56.4 pence was based on the average mid-market closing price of the Company's share over the 20 business days prior to the signing of the Revised Agreement on 18 March 2019. The Seller has entered into a lock-in and orderly market agreement which prevents him from selling the shares issued to him under the Revised Agreement until after the first anniversary of admission of these Ordinary Shares and governs the circumstances in which the Ordinary Shares issued to him can be disposed of during the 12 months following the first anniversary of the admission.

 

Application has been made for the 313,832 new Ordinary Shares to be admitted to trading on AIM ("Admission") and dealings are expected to commence on 4 October 2019. The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares.

 

The total number of Ordinary Shares in issue following Admission will be 95,532,628. Accordingly, the figure of 95,532,628 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

For further information, please contact:

Proactis Holdings PLC

 

Tim Sykes, Chief Executive Officer

 

01937 545070 x1115 investorcontact@proactis.com

 

 

finnCap Ltd

Stuart Andrews/Carl Holmes/Matthew Radley - Corporate Finance

Andrew Burdis/Richard Chambers - ECM

 

0207 220 0500

 

Alma PR

 

Rebecca Sanders-Hewett, Hilary Buchanan, Sam Modlin

020 3405 0205

 

Proactis@almapr.co.uk

 

Notes to Editors:

 

Proactis creates, sells and maintains software and services which enable organisations to streamline, control and monitor all indirect expenditure. Its solutions are used in approximately 1,000 buying organisations around the world from the commercial, public and not-for-profit sectors.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCDGGDCLDXBGCG

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.